alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
OFFICE OF THE AmORNEY GENERAL OF TEXAS 

AUSTIN 
ortioiels upon mqui8ition. At the and of eaoi math, 

th0 l OUUty WaitOr biu8 UOh OeiOm iOr th0 808t8 

OS the 8UQQiiOB U88d auring th8 month br the do&mtnont end ZOq Uir O8 th a l teoh l iilolel pay from It8 orfloor*s salary fund to the Oounty Oonorel md tha 

808t Of 8uOh 8Ugp1188 OrOd$ ~#lfiSO,, th. tOlO#&uIO 

8mOMO Or eeoh otti 18 mid Originally irom the 

Qouaty Oonorel Fund end in tuq #ill& to l oh tiffi81ir. 

. u8 pt.- th. 8OUIltr OrOslrrrl it8 Off108 

8Um11.8, l t.etiOllO~, pl’iltting, 'ito., in l OOOrdantM 

rith,the l)?0V%810llO Of hX't101*8 Ib sa sl , t 8OQa 8. 0. & , 

39i2b a nd the & wtwelly rroo@ ilsmo d l. that ih. mmtlli88~OM rl O8Ud ~ 18 tO8t.d With 

6iXOOt th0 tinanbiti mar8 Of tE 

,,;uWyUWt&B Uld 

800 11 Tu. air, ,608s 

%hO 8&&-t. Of Ut OttiOOr*8 80irj iurrd 

br. l eoh l rrioe I+ +OWtti~8 *it. more aen 190,000 pqlrtlcln 18 8enotIonod by 8OOtiOn 19(I) 0r U'tiOh S91~8, 

~WllOlt’B hllOtOtOd &V18Od @iril 8ttltU~O8, Tai8 8tStute~8ont4a~~~tolloriry~~1 

** * l 8uoh fund mhell bo kept soparet@ 8nb apart iton ell other Oountf fqu.lrr 

qnd 8hel.l be hold end dirburred ~for the paw- 

! 

080 of paying the 8abiX'y ot suoh Offleer, 

h0 SOwlO Of hi8 dOpUtlO8, Ub818tEiIitS,. 

81.X-k&, .8tOtlO@U$lW8, .md inV@8ti&Or8 Who 

are ‘eu’thorized to draw a aalery,Zrom said 

fl$iht$ihX? thb proY181058 Oi this WeOtiOn 

pay the euthori5wl end aDDI'OV@d ox-:- 

pm8Or 0r hi0 0frioe l z* -sUndarsoorZng oti8 1. 

89b8eOtIoI% (kj if th0M8 Aid -OO&eIM 

r0ii0aingt 

th0 

l * * * the Ooprmf8810nOP8* 8OWt 8hhl3. 

transfer rroln the tMa0cdl J'uu~ of th9 CJoUUt~ 

. 
.tuo iy o?~Ioor~8’8elery h na l r 8u.h multy 

suoh fund8 a8 may be 800088ey to pay tha 

ulerlor end other lwelly l uthorirod elm 

s 

* + * @nborroorxne ours).= 

8Ubr@OtiOn (1) 80nkiar th.'follmty pox?- 

tinult 1angug~1 

‘At th8 s1088 #$ uoh month b? tha 

tomro o? hia etrlo~, uoh orrlorr w 

hounln .aEall Rake u 8’ 

ZWJUir@d by 8ubwotI& T0) ”t 

or th0 -port 

of thi8 88OtiOn 

an ftemisod snd morn etetment or eU. muThe iongoing plW18iOM or ~ornon~s Art, 

SOUrn, See,-19, are e pert or the orlglnel wrloer*s 

Bahry Bil& 

.8t it8 BOOOn r 

8806 by %ho ~~y-rOurth'kgi8le~ 

Odl1.d 8e88iOlt. 

LIW8 of -Us, yOrty-fourth Lo P O l~?d, l t'S.q.) 

8i 

Oenarel and m801ti 

slaturo, Vol. S at 

9h%8 lO&i8~tiOn W88 lk~&WWOd 08 

WOTMbe? 15 1.935 end by it8 an tUm8 booem 8ttOOtiVo 

on amuary i, lOW* 

kX'tio10 5899b of ~8l!tlQtl'8 Annotated Oiril 

8tetUtw8, Olted. by you, 18 not &mad by us to be in 

8OtIfuOt With th0 O?riOW’8 Stiarp Bill, .bUt. m b0 

8OlllltPlOd in 80n80Mno* thoroulth. Rowwer, ir then 

be eoarllot, tha 8tetuta lert noelring ep x-oral 

would oontrol. ht. SSQ9b we8 parsed 0 &Yin 

loco, the la8t amendment theroto ~booomlng the law 
. 

. 

_..
38928.

#### STATE HIGHWAY DEPARTMENT v. MORTON *et al.*

Decided June 19, 1961

Rehearing denied July 5,1961.

*107
      *Eugene Cook, Attorney-General, Carter Goode, E. J. Summerour, Assistant Attorneys-General, George L. Jackson,*for plaintiff in error.

*J. Pierce Anderson,*contra.

Eberhardt, Judge.

The evidence objected to was clearly admissible and there was no error in overruling the objections thereto. It will be seen that the condemnor was seeking to acquire all rights of every kind, including those of a licensee or permittee, and in such a proceeding the condemnee is entitled to prove every element of consequential damage that may be relevant. There was no evidence as to whether the “permit” *108to install the water line was written or oral or as to what the terms thereof may have been. But it is obvious that the condemnee had, on the faith of the license or permit, expended money in laying and installing the water line. The license or permit, not otherwise terminated, was sought to be condemned in this proceeding. Consequently, the loss of the line, or the interruption of a water supply by reason thereof, is an element of consequential damage, and evidence thereof was properly admitted. *Code*§ 85-1404.

The testimony that the interruption of the water supply would make it necessary to drill a well to replace it was enough to support the estimate of $3,000 in consequential damages. Moreover, this testimony was elicited on cross-examination by the condemnor.

The general grounds of the motion were expressly abandoned in the oral arguments before the court.

*Judgment affirmed.*

*Carlisle, P. J., and Niohols, J., concur.*
§ 571.100 Regulation based on petition. ( a ) The Commissioner will forward for publication in the Federal Register, within 90 days after filing of the petition (or within 180 days if the time is extended as provided for in section 409(c)(2) of the act), a regulation prescribing the conditions under which the food additive may be safely used (including, but not limited to, specifications as to the particular food or classes of food in or on which such additive may be used, the maximum quantity that may be used or permitted to remain in or on such food, the manner in which such additive may be added to or used in or on such food, and any directions or other labeling or packaging requirements for such additive deemed necessary by him to assure the safety of such use), and prior to the forwarding of the order to the Federal Register for publication shall notify the petitioner of such order and the reasons for such action; or by order deny the petition, and shall notify the petitioner of such order and of the reasons for such action.
( b ) If the Commissioner determines that additional time is needed to study and investigate the petition, he shall by written notice to the petitioner extend the 90-day period for not more than 180 days after the filing of the petition.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               SEP-30-1999
<CASH>                                          36,012
<SECURITIES>                                    86,876
<RECEIVABLES>                                   32,142
<ALLOWANCES>                                     2,605
<INVENTORY>                                        852
<CURRENT-ASSETS>                               168,243
<PP&E>                                          38,600
<DEPRECIATION>                                  17,607
<TOTAL-ASSETS>                                 204,128
<CURRENT-LIABILITIES>                           43,505
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        72,527
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   204,128
<SALES>                                        200,012
<TOTAL-REVENUES>                               200,012
<CGS>                                           17,795
<TOTAL-COSTS>                                   17,795
<OTHER-EXPENSES>                               134,295
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  91
<INCOME-PRETAX>                                 52,324
<INCOME-TAX>                                    13,604
<INCOME-CONTINUING>                             38,720
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    38,720
<EPS-BASIC>                                       1.28
<EPS-DILUTED>                                     1.23


</TABLE>
# C_2015381EN.01003901.xml

| 16.11.2015 | EN | Official Journal of the European Union | C 381/39 |
| --- | --- | --- | --- |

16.11.2015

EN

Official Journal of the European Union

C 381/39

---

Order of the General Court of 14 September 2015 — Spain v Commission

(Case T-841/14) (1)

1

((Action for annulment - Own resources of the European Union - Financial liability of the Member States - Obligation to pay the Commission the amount corresponding to a loss of own resources - Amount of default interest - Letter from the Commission - Act not subject to appeal - Inadmissible))

(2015/C 381/45)

Language of the case: Spanish

Parties

Parties

Applicant: Kingdom of Spain (represented by: A. Gavela Llopis, abogado del Estado)

Applicant:

Defendant: Commission (represented by: A. Caeiros and L. Lozano Palacios, acting as Agents)

Defendant:

Re:

Re:

Application for annulment of the decision allegedly made by the Commission’s Directorate-General for Budget contained in the letter (BUDG/B/03MV D (2014) 3486706 of 21 October 2014, by which the Commission applied Article 11 of amended Council Regulation (EC, Euratom) No 1150/2000 of 22 May 2000 implementing Decision 2007/436/EC, Euratom on the system of the European Communities’ own resources (OJ 2007 L 130, p. 1) and fixed at EUR 3 1 72  388,46 the amount of default interest to be paid by the Kingdom of Spain, at the latest on the last working day two months following the dispatch of that letter.

Operative part of the order

Operative part of the order

| 1. | The action is dismissed. |
| --- | --- |

1.

The action is dismissed.

| 2. | The Kingdom of Spain shall bear the costs. |
| --- | --- |

2.

The Kingdom of Spain shall bear the costs.

---

(1)  OJ C 73, 2.3.2015.

1

---
§ 133.128 Cottage cheese. ( a ) Cottage cheese is the soft uncured cheese prepared by mixing cottage cheese dry curd with a creaming mixture as provided in paragraph (b) of this section. The milkfat content is not less than 4 percent by weight of the finished food, within limits of good manufacturing practice. The finished food contains not more than 80 percent of moisture, as determined by the method prescribed in § 133.129(a).
( b ) The creaming mixture is prepared from safe and suitable ingredients including, but not limited to, milk or substances derived from milk. Any ingredients used that are not derived from milk shall serve a useful function other than building the total solids content of the finished food, and shall be used in a quantity not greater than is reasonably required to accomplish their intended effect. The creaming mixture shall be pasteurized; however, heat labile ingredients, such as bacterial starters, may be added following pasteurization.
( c ) The name of the food consists of the following two phrases which shall appear together: ( 1 ) The words “cottage cheese” which shall appear in type of the same size and style.
( 2 ) The statement “not less than __ percent milkfat” or “__ percent milkfat minimum”, the blank being filled in with the whole number that is closest to, but does not exceed, the actual fat content of the product. This statement of fat content shall appear in letters not less than one-half of the height of the letters in the phrase specified in paragraph (c)(1) of this section, but in no case less than one-eighth of an inch in height.
( d ) When the optional process described in § 133.129(b)(1) (ii) or (iii) is used to make the cottage cheese dry curd used in cottage cheese, the label shall bear the statement “Directly set” or “Curd set by direct acidification”. Wherever the name of the food appears on the label so conspicuously as to be seen under customary conditions of purchase, the statement specified in this paragraph, showing the optional process used, shall immediately and conspicuously precede or follow such name without intervening written, printed, or graphic matter.
( e ) Each of the ingredients used in the food shall be declared on the label as required by the applicable sections of parts 101 and 130 of this chapter, except that milk-clotting enzymes may be declared by the word “enzymes”.
[42 FR 14366, Mar. 15, 1977, as amended at 58 FR 2892, Jan. 6, 1993]
**Exhibit 32.2**

 

**CERTIFICATION PURSUANT TO**

 

**18 U.S.C. SECTION 1350,**

 

**AS ADOPTED PURSUANT TO**

 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theQuarterly Report on Form 10-Q of Ebix, Inc. (the “Company”) for the quarterlyperiod ended June 30, 2004, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Richard J. Baum, ChiefFinancial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, asadopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complieswith the requirements of section 13(a) or 15(d) of the Securities Exchange Actof 1934; and

 

2. The information contained inthe Report fairly presents, in all material respects, the financial conditionand results of operations of the Company.

 

 
| By:                      | /s/ Richard  J. Baum |   |
|--------------------------|----------------------|--------|
|                     |                 |
| Name:                    | Richard J.  Baum     |   |
|                     |                 |
| Chief  Financial Officer |                 |
|                     |                 |
| August 16,  2004         |                 |
|                          |                      |        |  |

 

1

----
EXHIBIT 11 - CALCULATION OF NET INCOME (LOSS) PER COMMON SHARE

                                  MICROAGE, INC
                 NET INCOME (LOSS) PER COMMON SHARE CALCULATION
                                 (in thousands)

<TABLE>
<CAPTION>

                                                Quarter ended       26 weeks ended
                                             ------------------   -------------------
                                              May 3,     May 4,    May 3,      May 4,
                                               1998       1997      1998        1997
                                             -------    -------   --------    -------
<S>                                           <C>        <C>        <C>        <C>
BASIC
 Weighted average common shares               19,584     16,404     19,520     16,323
                                             -------    -------   --------    -------

DILUTED
 Weighted average shares from
  primary calculation                         19,584     16,404     19,520     16,323

 Dilutive effect of stock options
  and warrants                                    --        540         --        806
                                             -------    -------   --------    -------
   Weighted average common and common
    equivalent shares outstanding - diluted   19,584     16,944     19,520     17,129
                                             -------    -------   --------    -------

NET INCOME  (LOSS)                           $(5,957)   $ 6,376   $(12,073)   $11,446

Net income (loss) per common and
 common equivalent share:
  Basic                                      $ (0.30)   $  0.39   $  (0.62)   $  0.70
                                             =======    =======   ========    =======
  Diluted                                    $ (0.30)   $  0.38   $  (0.62)   $  0.67
                                             =======    =======   ========    =======
</TABLE>
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.2540 Microbiological incubator. ( a ) *Identification.* A microbiological incubator is a device with various chambers or water-filled compartments in which controlled environmental conditions, particularly temperature, are maintained. It is intended for medical purposes to cultivate microorganisms and aid in the diagnosis of disease.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9. The device is also exempt from the good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[47 FR 50823, Nov. 9, 1982, as amended at 66 FR 38791, July 25, 2001]
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.4100 Extracorporeal circuit and accessories for long-term respiratory/cardiopulmonary failure. ( a ) *Identification.* An extracorporeal circuit and accessories for long-term respiratory/cardiopulmonary support (>6 hours) is a system of devices and accessories that provides assisted extracorporeal circulation and physiologic gas exchange of the patient's blood in patients with acute respiratory failure or acute cardiopulmonary failure, where other available treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent. The main devices and accessories of the system include, but are not limited to, the console (hardware), software, and disposables, including, but not limited to, an oxygenator, blood pump, heat exchanger, cannulae, tubing, filters, and other accessories (*e.g.,* monitors, detectors, sensors, connectors).
( b ) *Classification* —Class II (special controls). The special controls for this device are: ( 1 ) The technological characteristics of the device must ensure that the geometry and design parameters are consistent with the intended use, and that the devices and accessories in the circuit are compatible;
( 2 ) The devices and accessories in the circuit must be demonstrated to be biocompatible;
( 3 ) Sterility and shelf-life testing must demonstrate the sterility of any patient-contacting devices and accessories in the circuit and the shelf life of these devices and accessories;
( 4 ) Non-clinical performance evaluation of the devices and accessories in the circuit must demonstrate substantial equivalence of the performance characteristics on the bench, mechanical integrity, electromagnetic compatibility (where applicable), software, durability, and reliability;
( 5 ) In vivo evaluation of the devices and accessories in the circuit must demonstrate their performance over the intended duration of use, including a detailed summary of the clinical evaluation pertinent to the use of the devices and accessories to demonstrate their effectiveness if a specific indication (patient population and/or condition) is identified; and
( 6 ) Labeling must include a detailed summary of the non-clinical and in vivo evaluations pertinent to use of the devices and accessories in the circuit and adequate instructions with respect to anticoagulation, circuit setup, performance characteristics with respect to compatibility among different devices and accessories in the circuit, and maintenance during a procedure.
[81 FR 7451, Feb. 12, 2016]
EXHIBIT 5.1

                     [Letterhead of Ritchie & Johnson, PLC]

                                  May 19, 2000

Board of Directors
BankFirst Corporation
625 Market Street
Knoxville, Tennessee  37902

Re: Registration Statement on Form S-8
    Relating to the Plan Shares Issuable Pursuant to the
    BankFirst Corporation Stock Option Plan

Gentlemen:

We have acted as counsel for BankFirst Corporation, a Tennessee corporation (the
"Company"), in connection with the Registration Statement on Form S-8 (the
"Registration Statement") filed by the Company on May 19, 2000 with the
Securities and Exchange Commission (the "Commission") under the Securities Act
of 1933, as amended, with respect to 3,125,000 shares of the Company's common
stock, par value $2.50 per share (the "Plan Shares"), issuable pursuant to
awards under the Company's Stock Option Plan (the "Plan") as referenced in the
Registration Statement.

In rendering this opinion, we have relied upon, among other things, our
examination of such documents and records of the Company and certificates of its
officers and of public officials as we have deemed necessary for purposes of the
opinions expressed below.

Based upon the foregoing, we are of the opinion that:

1.    The Company is duly incorporated, validly existing and in good standing
      under the laws of the State of Tennessee; and

2.    The issuance of the Plan Shares has been validly authorized by the Company
      and, upon issuance pursuant to the terms of the Plan, the Plan Shares will
      be legally issued, fully paid and non-assessable.


<PAGE>

Page2
Board of Directors - BankFirst Corporation
Re: Registration Statement on Form S-8
    Relating to the Plan Shares Issuable Pursuant to the
    BankFirst Corporation Stock Option Plan
May 19, 2000


We hereby consent to the filing of this opinion with the Commission as Exhibit
5.1 to the Registration Statement.

                                            Sincerely yours,

                                            /s/ Wilson S. Ritchie
                                            -------------------------
                                            Wilson S. Ritchie
Exhibit 99.1




Annual Servicer’s Certificate


Provided by Nissan Motor Acceptance Corporation


to Holders of Notes and Certificates









NISSAN MOTOR ACCEPTANCE CORPORATION




OFFICER'S CERTIFICATE


The undersigned, Michael J. McConnell, Vice President of NISSAN MOTOR ACCEPTANCE CORPORATION, a California corporation (the “Company”), does hereby certify, in his capacity as such corporate officer, as follows:
  (1)           The undersigned has caused a review, under his supervision, to be made of i) the activities; and ii) the performance under the Agreement (as defined below), of the Company during the period from July 22, 2015 through March 31, 2016 (the “Reporting Period”); and
  (2)           To the best of the undersigned’s knowledge, based upon such review, the Company has fulfilled its obligations in all material respects under the Agreement throughout the Reporting Period.
  This Officer’s Certificate is being furnished pursuant to Section 4.09(a) of that certain Sale and Servicing Agreement, dated as of July 22, 2015 (the “Agreement”), by and among the Company, in its individual capacity and as servicer, Nissan Auto Receivables Corporation II, as seller, and Nissan Auto Receivables 2015-B Owner Trust.
  Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Agreement.


IN WITNESS WHEREOF, I have set my hand effective as of the 15th day of June, 2016.




/s/Michael J. McConnell________________


Michael J. McConnell


Vice President